ICON's global team of experts has extensive experience in a broad of therapeutic areas

  • 40%

    Projects focused in oncology
  • 200

    Clinical trials in vaccines over the past five years
  • 5,700 Sites

    Worldwide in CNS studies

From initial strategy development all the way through to pricing and market access recommendations.

Arrange a Meeting

With one of our Therapeutic Experts today.